MedTrace Logo

Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement

NCT03247023 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2026-06-22

Study results available
· View outcomes & findings →

Summary

This study will evaluate the long term performance and safety data for the Cadence™ Total Ankle System (CTAS) when used for primary arthroplasty in patients with primary arthritis (e.g. degenerative disease), secondary arthritis (e.g. post-traumatic, avascular necrosis, if minimally 2/3 of the talus is preserved), and systemic arthritis of the ankle (e.g. rheumatoid arthritis, hemochromatosis)

Conditions

Interventions

DEVICE

Implantation of Integra Cadence Total Ankle System

Primary Ankle Arthroplasty

Sponsors & Collaborators

  • Smith & Nephew Orthopaedics AG

    collaborator INDUSTRY

  • Smith & Nephew, Inc.

    lead INDUSTRY

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-18
Primary Completion
2023-09-06
Completion
2023-09-06

Countries

  • Belgium
  • Canada
  • France
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03247023 on ClinicalTrials.gov